The Biomechanisms of metal and metal-oxide nanoparticles’ interactions with cells

International Journal of Environmental Research and Public Health

Volumn 12, Issue 2, 2015, Pages 1112-1134

  Teske, Sondra S ^a   Detweiler, Corrella S ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Biomechanism; Metal oxide; Nanoparticle; Nanotoxicology; QSAR model

Indexed keywords

COPPER; CYCLOOXYGENASE 2; DOXORUBICIN; HYDROGEN PEROXIDE; IRON; IRON OXIDE; LIPOSOME; METAL; METAL NANOPARTICLE; METAL OXIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; NANOPARTICLE; PROTEIN KINASE B; PROTEIN P53; REACTIVE OXYGEN METABOLITE; SILICON DIOXIDE; STAT1 PROTEIN; TRANSCRIPTION FACTOR E2F; TUMOR NECROSIS FACTOR ALPHA; OXIDE;

BIOMECHANICS; CELL ORGANELLE; METAL; OXIDE; PARTICULATE MATTER; PHYSICOCHEMICAL PROPERTY; THERMODYNAMICS; TOXICITY; TOXICOLOGY;

ADSORPTION; ALPHA HELIX; APOPTOSIS; BIOENGINEERING; BIOMECHANICS; CARCINOGENESIS; CELL CULTURE; CELL DEATH; CELL INTERACTION; CELL PROLIFERATION; CHEMICAL REACTION; COLLOID; DENSITY FUNCTIONAL THEORY; DISSOLUTION; DNA DAMAGE; EFFECT SIZE; ENDOCYTOSIS; ENERGY TRANSFER; ENTHALPY; ENZYME ACTIVITY; FENTON REACTION; GENOTOXICITY; HIGH THROUGHPUT SCREENING; HUMAN; HYDROPHOBICITY; IONIC STRENGTH; ISOELECTRIC POINT; LIPID BILAYER; NANOTOXICOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATION REDUCTION STATE; PROTEIN AGGREGATION; PROTEIN CROSS LINKING; PROTEIN FOLDING; QUANTITATIVE ANALYSIS; REVIEW; SIGNAL TRANSDUCTION; STATIC ELECTRICITY; STRUCTURE ACTIVITY RELATION; THERMODYNAMICS; ULTRAVIOLET RADIATION; ZETA POTENTIAL; ANIMAL; CELLS; CHEMISTRY; DRUG EFFECTS;

ANIMALIA;

ANIMALS; CELLS; HUMANS; METAL NANOPARTICLES; OXIDES;

EID: 84921878601     PISSN: 16617827     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph120201112     Document Type: Review

References (75)

1. Oberdörster, G. Safety assessment for nanotechnology and nanomedicine: Concepts of nanotoxicology. J. Int. Med. 2010, 267, 89-105.
2. Zolnik, B.S.; Gonzalez-Fernandez, A.; Sadrieh, N.; Dobrovolskaia, M.A. Minireview: Nanoparticles and the immune system. Endocrinology 2010, 151, 458-465.
3. Shi, H.; Magaye, R.; Castranova, V.; Zhao, J. Titanium dioxide nanoparticles: A review of current toxicological data. Part. Fibre Toxicol. 2013, 10, doi:10.1186/1743-8977-10-15.
4. Auffan, M.; Rose, J.; Wiesner, M.R.; Bottero, J.-Y. Chemical stability of metallic nanoparticles: A parameter controlling their potential cellular toxicity in vitro. Environ. Pollut. 2009, 157, 1127-1133.
5. Hotze, E.M.; Phenrat, T.; Lowry, G.V. Nanoparticle aggregation: Challenges to understanding transport and reactivity in the environment. J. Environ. Qual. 2010, 39, 1909-1924.
6. Baer, D.; Munusamy, P.; Karakoti, A.; Thevuthasan, S.; Kuchibhatla, S.; Seal, S. Ceria nanoparticles: Environmental impacts on particle structure and chemistry. In Bulletin of the American Physical Society; APS March Meeting: Boston, MA, USA, 2012; Volume 57.
7. Zhang, L.; Gu, F.X.; Chan, J.M.; Wang, A.Z.; Langer, R.S.; Farokhzad, O.C. Nanoparticles in medicine: Therapeutic applications and developments. Clin. Pharmacol. Ther. 2007, 83, 761-769.
8. Truong, L.; Zaikova, T.; Richman, E.K.; Hutchison, J.E.; Tanguay, R.L. Media ionic strength impacts embryonic responses to engineered nanoparticle exposure. Nanotoxicology 2012, 6, 691-699.
9. Nishanth, R.P.; Jyotsna, R.G.; Schlager, J.J.; Hussain, S.M.; Redddanna, P. Inflammatory responses of raw 264.7 macrophages upon exposure to nanoparticles: Role of ros-nfκb signaling pathway. Nanotoxicology 2011, 5, 502-516.
10. He, Y.T.; Wan, J.; Tokunaga, T. Kinetic stability of hematite nanoparticles: The effect of particle sizes. J. Nanopart. Res. 2008, 10, 321-332.
11. Liu, R.; Yin, L.H.; Pu, Y.P.; Li, Y.H.; Zhang, X.Q.; Liang, G.Y.; Li, X.B.; Zhang, J.; Li, Y.F.; Zhang, X.Y. The immune toxicity of titanium dioxide on primary pulmonary alveolar macrophages relies on their surface area and crystal structure. J. Nanosci. Nanotechnol. 2010, 10, 8491-8499.
12. Colvin, V.L. The potential environmental impact of engineered nanomaterials. Nat. Biotech. 2003, 21, 1166-1170.
13. Sayes, C.M.; Fortner, J.D.; Guo, W.; Lyon, D.; Boyd, A.M.; Ausman, K.D.; Tao, Y.J.; Sitharaman, B.; Wilson, L.J.; Hughes, J.B. et al. The differential cytotoxicity of water-soluble fullerenes. Nano Lett. 2004, 4, 1881-1887.
14. Aggarwal, P.; Hall, J.B.; McLeland, C.B.; Dobrovolskaia, M.A.; McNeil, S.E. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv. Drug Deliv. Rev. 2009, 61, 428-437.
15. Gupta, A.K.; Gupta, M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005, 26, 3995-4021.
16. Cui, Y.; Zhao, Y.; Tian, Y.; Zhang, W.; Lü, X.; Jiang, X. The molecular mechanism of action of bactericidal gold nanoparticles on Escherichia Coli. Biomaterials 2012, 33, 2327-2333.
17. Lok, C.-N.; Ho, C.-M.; Chen, R.; He, Q.-Y.; Yu, W.-Y.; Sun, H.; Tam, P.K.-H.; Chiu, J.-F.; Che, C.-M. Proteomic analysis of the mode of antibacterial action of silver nanoparticles. J. Proteom. Res. 2006, 5, 916-924.
18. Gopinath, P.; Gogoi, S.K.; Sanpui, P.; Paul, A.; Chattopadhyay, A.; Ghosh, S.S. Signaling gene cascade in silver nanoparticle induced apoptosis. Colloids Surf. B Biointerfaces 2010, 77, 240-245.
19. Lin, J.; Zhang, H.; Chen, Z.; Zheng, Y. Penetration of lipid membranes by gold nanoparticles: Insights into cellular uptake, cytotoxicity, and their relationship. ACS Nano 2010, 4, 5421-5429.
20. Harper, S.L.; Carriere, J.L.; Miller, J.M.; Hutchison, J.E.; Maddux, B.L.S.; Tanguay, R.L. Systematic evaluation of nanomaterial toxicity: Utility of standardized materials and rapid assays. ACS Nano 2011, 5, 4688-4697.
21. Zhang, H.D.; Daren, R.; Jiang, X.; Meng, H.; Sun, B.; Tarn, D.; Xue, M.; Wang, X.; Lin, S.; Ji, Z.; Zink, J.I.; Nel, A.; Brinker, C.J. Processing pathway dependence of amorphous silica nanoparticle toxicity—Colloidal versus pyrolytic. J. Am. Chem. Soc. 2012, 134, 15792-15804.
22. Kim, K.-T.; Tanguay, R.L. Integrating zebrafish toxicology and nanoscience for safer product development. Green Chem. 2013, 15, 872-880.
23. Lundqvist, M.; Stigler, J.; Elia, G.; Lynch, I.; Cedervall, T.; Dawson, K.A. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc. Natl. Acad. Sci. 2008, 105, 14265-14270.
24. Lynch, I.; Dawson, K.A. Protein-nanoparticle interactions. Nano Today 2008, 3, 40-47.
25. Viota, J.L.; González-Caballero, F.; Durán, J.D.G.; Delgado, A.V. Study of the colloidal stability of concentrated bimodal magnetic fluids. J. Colloid. Interface Sci. 2007, 309, 135-139.
26. Dutta, D.; Sundaram, S.K.; Teeguarden, J.G.; Riley, B.J.; Fifield, L.S.; Jacobs, J.M.; Addleman, S.R.; Kaysen, G.A.; Moudgil, B.M.; Weber, T.J. Adsorbed proteins influence the biological activity and molecular targeting of nanomaterials. Toxicol. Sci. 2007, 100, 303-315.
27. Morones, J.R.; Elechiguerra, J.L.; Camacho, A.; Holt, K.; Kouri, J.B.; Ramírez, J.T.; Yacaman, M.J. The bactericidal effect of silver nanoparticles. Nanotechnology 2005, 16, 2346-2353.
28. Monopoli, M.P.; Åberg, C.; Salvati, A.; Dawson, K.A. Biomolecular coronas provide the biological identity of nanosized materials. Nat. Nanotechnol. 2012, 7, 779-786.
29. Goppert, T.M.; Muller, R.H. Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: Comparison of plasma protein adsorption patterns. J. Drug Target. 2005, 13, 179-187.
30. Kim, J.A.; Salvati, A.; Åberg, C.; Dawson, K.A. Suppression of nanoparticle cytotoxicity approaching in vivo serum concentrations: Limitations of in vitro testing for nanosafety. Nanoscale 2014, 6, 14180-14184.
31. Wang, F.; Yu, L.; Monopoli, M.P.; Sandin, P.; Mahon, E.; Salvati, A.; Dawson, K.A. The biomolecular corona is retained during nanoparticle uptake and protects the cells from the damage induced by cationic nanoparticles until degraded in the lysosomes. Nanomed. Nanotechnol. Biol. Med. 2013, 9, 1159-1168.
32. Salvati, A.; Pitek, A.S.; Monopoli, M.P.; Prapainop, K.; Bombelli, F.B.; Hristov, D.R.; Kelly, P.M.; Åberg, C.; Mahon, E.; Dawson, K.A. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat. Nanotechnol. 2013, 8, 137-143.
33. Anguissola, S.; Garry, D.; Salvati, A.; O’Brien, P.J.; Dawson, K.A. High content analysis provides mechanistic insights on the pathways of toxicity induced by amine-modified polystyrene nanoparticles. PLoS ONE 2014, 9, doi:10.1371/journal.pone.0108025.
34. Xia, T.; Kovochich, M.; Liong, M.; Mädler, L.; Gilbert, B.; Shi, H.; Yeh, J.I.; Zink, J.I.; Nel, A.E. Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS Nano 2008, 2, 2121-2134.
35. Iversen, T.-G.; Skotland, T.; Sandvig, K. Endocytosis and intracellular transport of nanoparticles: Present knowledge and need for future studies. Nano Today 2011, 6, 176-185.
36. Chen, M.; von Mikecz, A. Formation of nucleoplasmic protein aggregates impairs nuclear function in response to SiO2 nanoparticles. Exp. Cell Res. 2005, 305, 51-62.
37. Vertegel, A.A.; Siegel, R.W.; Dordick, J.S. Silica nanoparticle size influences the structure and enzymatic activity of adsorbed lysozyme. Langmuir 2004, 20, 6800-6807.
38. Xu, Z.; Liu, X.-W.; Ma, Y.-S.; Gao, H.-W. Interaction of nano-TiO2 with lysozyme: Insights into the enzyme toxicity of nanosized particles. Environ. Sci. Pollut. Res. 2010, 17, 798-806.
39. Chakraborti, S.; Chatterjee, T.; Joshi, P.; Poddar, A.; Bhattacharyya, B.; Singh, S.P.; Gupta, V.; Chakrabarti, P. Structure and activity of lysozyme on binding to ZnO nanoparticles. Langmuir 2009, 26, 3506-3513.
40. Linse, S.; Cabaleiro-Lago, C.; Xue, W.-F.; Lynch, I.; Lindman, S.; Thulin, E.; Radford, S.E.; Dawson, K.A. Nucleation of protein fibrillation by nanoparticles. Proc. Natl Acad. Sci. 2007, 104, 8691-8696.
41. Stradner, A.; Sedgwick, H.; Cardinaux, F.; Poon, W.C.; Egelhaaf, S.U.; Schurtenberger, P. Equilibrium cluster formation in concentrated protein solutions and colloids. Nature 2004, 432, 492-495.
42. Xia, X.-R.; Monteiro-Riviere, N.A.; Riviere, J.E. An index for characterization of nanomaterials in biological systems. Nat Nano 2010, 5, 671-675.
43. Neouze, M.-A.; Schubert, U. Surface modification and functionalization of metal and metal oxide nanoparticles by organic ligands. Monatshefte fűr Chemie Chem. Mon. 2008, 139, 183-195.
44. Truonga, L.; Sailia, K.S.; Millerd, J.M.; Hutchisond, J.E.; Tanguaya, R.L. Persistent adult zebrafish behavioral deficits results from acute embryonic exposure to gold nanoparticles. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2012, 155, 269-274.
45. Palocci, C.; Chronopoulou, L.; Venditti, I.; Cernia, E.; Diociaiuti, M.; Fratoddi, I.; Russo, M.V. Lipolytic enzymes with improved activity and selectivity upon adsorption on polymeric nanoparticles. Biomacromolecules 2007, 8, 3047-3053.
46. Asuri, P.; Bale, S.S.; Pangule, R.C.; Shah, D.A.; Kane, R.S.; Dordick, J.S. Structure, function, and stability of enzymes covalently attached to single-walled carbon nanotubes. Langmuir 2007, 23, 12318-12321.
47. Rehman, M.U.; Yoshihisa, Y.; Miyamoto, Y.; Shimizu, T. The anti-inflammatory effects of platinum nanoparticles on the lipopolysaccharide-induced inflammatory response in raw 264.7 macrophages. Inflamm. Res. 2012, 61, 1177-1185.
48. Ma, J.S.; Kim, W.J.; Kim, J.J.; Kim, T.J.; Ye, S.K.; Song, M.D.; Kang, H.; Kim, D.W.; Moon, W.K.; Lee, K.H. Gold nanoparticles attenuate lps-induced no production through the inhibition of nf-κb and ifn-β/stat1 pathways in raw264.7 cells. Nitr. Oxide 2010, 23, 214-219.
49. Kodali, V.; Littke, M.H.; Tilton, S.C.; Teeguarden, J.G.; Shi, L.; Frevert, C.W.; Wang, W.; Pounds, J.G.; Thrall, B.D. Dysregulation of macrophage activation profiles by engineered nanoparticles. ACS Nano 2013, 7, 6997-7010.
50. Burello, E.; Worth, A.P. QSAR modeling of nanomaterials. Nanomed. Nanobiotechnol. 2011, 3, 298-306.
51. Fourches, D.; Pu, D.; Tassa, C.; Weissleder, R.; Shaw, S.Y.; Mumper, R.J.; Tropsha, A. Quantitative nanostructure-activity relationship modeling. ACS Nano 2010, 4, 5703-5712.
52. Rallo, R.; France, B.; Liu, R.; Nair, S.; George, S.; Damoiseaux, R.; Giralt, F.; Nel, A.; Bradley, K.; Cohen, Y. Self-organizing map analysis of toxicity-related cell signaling pathways for metal and metal oxide nanoparticles. Environ. Sci. Technol. 2011, 45, 1695-1702.
53. Burello, E.; Worth, A.P. A theoretical framework for predicting the oxidative stress potential of oxide nanoparticles. Nanotoxicology 2011, 5, 228-235.
54. Xu, Y.; Schoonen, M.A.A. The absolute energy positions of conduction and valence bands of selected semiconducting minerals. Am. Mineral. 2000, 85, 543-556.
55. Brunner, T.J.; Wick, P.; Manser, P.; Spohn, P.; Grass, R.N.; Limbach, L.K.; Bruinink, A.; Stark, W.J. In vitro cytotoxicity of oxide nanoparticles: Comparison to asbestos, silica, and the effect of particle solubility. Environ. Sci. Technol. 2006, 40, 4374-4381.
56. Zhang, H.; Ji, Z.; Xia, T.; Meng, H.; Low-Kam, C.; Liu, R.; Pokhrel, S.; Lin, S.; Wang, X.; Liao, Y.-P. et al. Use of metal oxide nanoparticle band gap to develop a predictive paradigm for oxidative stress and acute pulmonary inflammation. ACS Nano 2012, 6, 4349-4368.
57. Puzyn, T.; Rasulev, B.; Gajewicz, A.; Hu, X.; Dasari, T.P.; Michalkova, A.; Hwang, H.-M.; Toropov, A.; Leszczynska, D.; Leszczynski, J. Using nano-QSAR to predict the cytotoxicity of metal oxide nanoparticles. Nat. Nano 2011, 6, 175-178.
58. Hu, X.; Cook, S.; Wang, P.; Hwang, H.-M. In vitro evaluation of cytotoxicity of engineered metal oxide nanoparticles. Sci. Total Environ. 2009, 407, 3070-3072.
59. Cho, W.-S.; Duffin, R.; Thielbeer, F.; Bradley, M.; Megson, I.L.; MacNee, W.; Poland, C.A.; Tran, C.L.; Donaldson, K. Zeta potential and solubility to toxic ions as mechanisms of lung inflammation caused by metal/metal oxide nanoparticles. Toxicol. Sci. 2012, 126, 469-477.
60. Truong, L.; Moody, I.; Stankus, D.; Nason, J.; Lonergan, M.; Tanguay, R. Differential stability of lead sulfide nanoparticles influences biological responses in embryonic zebrafish. Arch. Toxicol. 2011, 85, 787-798.
61. Weissleder, R.; Kelly, K.; Sun, E.Y.; Shtatland, T.; Josephson, L. Cell-specific targeting of nanoparticles by multivalent attachment of small molecules. Nat. Biotech. 2005, 23, 1418-1423.
62. Shaw, S.Y.; Westly, E.C.; Pittet, M.J.; Subramanian, A.; Schreiber, S.L.; Weissleder, R. Perturbational profiling of nanomaterial biologic activity. Proc. Natl. Acad. Sci. 2008, 105, 7387-7392.
63. Fourches, D.; Pu, D.; Tropsha, A. Exploring quantitative nanostructure-activity relationships (QNAR) modeling as a tool for predicting biological effects of manufactured nanoparticles. Combinator. Chem. High Throughput Screen. 2011, 14, 217-225.
64. Modo, M.M.J.; Bulte, J.W.M. Molecular and Cellular MR Imaging; CRC Press, Taylor & Francis Group: Boca Raton, FL, USA, 2007.
65. Winkler, D.A.; Mombelli, E.; Pietroiusti, A.; Tran, L.; Worth, A.; Fadeel, B.; McCall, M.J. Applying quantitative structure-activity relationship approaches to nanotoxicology: Current status and future potential. Toxicology 2013, 313, 15-23.
66. Davis, R.M.; Balasubrasmaniam, S.; Kayandan, S.; Pothayee, N.; Hu, N.; Lin, Y.; Pothayee, N.; Koretsky, A.; House, M.; Woodward, R. et al. Structure-relaxivity relationships of well-defined magnetite clusters for sensitive magnetic resonance imaging. In Proceedings of AICHe Annual Meeting, Hilton San Francisco Union Square, San Francisco, CA, USA, 3-8 November 2013.
67. Knudsen, T.B.; Houck, K.A.; Sipes, N.S.; Singh, A.V.; Judson, R.S.; Martin, M.T.; Weissman, A.; Kleinstreuer, N.C.; Mortensen, H.M.; Reif, D.M. et al. Activity profiles of 309 ToxCast™ chemicals evaluated across 292 biochemical targets. Toxicology 2011, 282, 1-15.
68. Matthews, E.J.; Kruhlak, N.L.; Cimino, M.C.; Benz, R.D.; Contrera, J.F. An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: I. Identification of carcinogens using surrogate endpoints. Regul. Toxicol. Pharmacol. 2006, 44, 83-96.
69. Matthews, E.J.; Kruhlak, N.L.; Cimino, M.C.; Benz, R.D.; Contrera, J.F. An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: II. Identification of genotoxicants, reprotoxicants, and carcinogens using in silico methods. Regul. Toxicol. Pharmacol. 2006, 44, 97-110.
70. Rohde, C.B.; Zeng, F.; Gonzalez-Rubio, R.; Angel, M.; Yanik, M.F. Microfluidic system for on-chip high-throughput whole-animal sorting and screening at subcellular resolution. Proc. Natl. Acad. Sci. 2007, 104, 13891-13895.
71. Ahamed, M.; Posgai, R.; Gorey, T.J.; Nielsen, M.; Hussain, S.M.; Rowe, J.J. Silver nanoparticles induced heat shock protein 70, oxidative stress and apoptosis in Drosophila melanogaster. Toxicol. Appl. Pharmacol. 2010, 242, 263-269.
72. Vecchio, G.; Galeone, A.; Brunetti, V.; Maiorano, G.; Rizzello, L.; Sabella, S.; Cingolani, R.; Pompa, P.P. Mutagenic effects of gold nanoparticles induce aberrant phenotypes in Drosophila melanogaster. Nanomed. Nanotechnol. Biol. Med. 2012, 8, 1-7.
73. Pluskota, A.; Horzowski, E.; Bossinger, O.; von Mikecz, A. In Caenorhabditis elegans nanoparticle-bio-interactions become transparent: Silica-nanoparticles induce reproductive senescence. PLoS ONE 2009, 4, doi:10.1371/journal.pone.0006622.
74. Truong, L.; Reif, D.M.; St Mary, L.; Geier, M.C.; Truong, H.D.; Tanguay, R.L. Multidimensional in vivo hazard assessment using zebrafish. Toxicol. Sci. 2014, 137, 212-233.
75. Sayes, C.M.; Reed, K.L.; Warheit, D.B. Assessing toxicity of fine and nanoparticles: Comparing in vitro measurements to in vivo pulmonary toxicity profiles. Toxicol. Sci. 2007, 97, 163-180.